Itinai.com a close up shot of a scientist wearing a pristine db6a7c73 f520 44e3 bb74 10eabe38d600 0
Itinai.com a close up shot of a scientist wearing a pristine db6a7c73 f520 44e3 bb74 10eabe38d600 0

Awareness of digital tomosynthesis and attitudes towards breast cancer early diagnosis in women at first screening: findings from the IMPETO trial survey

Background

The European guidelines recommend using digital mammography (DM) or digital breast tomosynthesis (DBT) for screening women who are at average risk for breast cancer. A study called IMPETO in Tuscany, Italy, is looking into how effective DBT is for screening. There is not much information about how women feel about this new technology, so a survey was conducted to find out more.

Methods

In this study, 441 women aged 45 were surveyed to understand their knowledge of tomosynthesis and their views on early breast cancer diagnosis. The survey included questions about their background, awareness of tomosynthesis, breast density, and where they get information about breast health.

Results

Only 12% of the women knew what tomosynthesis was, and those who had previous mammograms were more likely to be aware of it. Over half of the participants (56.7%) had already undergone a mammogram. Education played a significant role; women with a secondary education were more likely to have had a mammogram before age 45. Most women who had a mammogram were advised by their gynecologist, while some made the decision on their own or followed their general practitioner’s advice.

Conclusion

This study shows that there is a need for better education about breast cancer screening and its risks. Tailored communication is essential to bridge the knowledge gap across different education levels without encouraging unnecessary screenings.

Opportunities for Improvement

Based on the trial data, clinics can:

  • Increase awareness of digital tomosynthesis among women.
  • Educate patients about the importance of early breast cancer diagnosis.
  • Utilize targeted communication strategies to reach women with varying educational backgrounds.

Measurable Outcomes

Clinics should aim to:

  • Increase the percentage of women aware of tomosynthesis from 12% to at least 30% within a year.
  • Improve the number of women participating in screenings by 20% over the next year.

AI Tools for Clinical Needs

Consider using AI solutions that can:

  • Analyze patient data to identify those at risk.
  • Provide personalized education materials based on individual needs.

Implementation Steps

Start with a pilot project to:

  • Test the effectiveness of AI solutions in increasing awareness and screening rates.
  • Track results and adjust strategies based on real-world impact.

Contact Us

For AI solutions in medical management, reach out to us:

AI-Powered Health Tools

Interactive AI Tools to Help You Understand Your Health

Solutions for Smart Healthcare

Clinical Research